Search Within

Gary Schwartz

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (38)
  2. Meeting Abstract (31)
Groups
  1. Epidemiology and Biostatistics (69)
  2. Biostatistics Service (68)
  3. Department of Medicine (59)
  4. Solid Tumor Oncology Division (58)
  5. Center for Pancreatic Cancer Research (30)
  6. GSK Faculty (28)

More Groups

People
  1. Richard Carvajal (30)
  2. Mithat Gonen (22)
  3. Manish Shah (21)
  4. Li-Xuan Qin (19)
  5. Mark Dickson (19)
  6. David Kelsen (17)

More People

Years
  1. 2016 (1)
  2. 2015 (1)
  3. 2014 (5)
  4. 2013 (15)
  5. 2012 (8)
  6. 2011 (5)

More Years

Publications
  1. Journal of Clinical Oncology (30)
  2. Clinical Cancer Research (13)
  3. Cancer Chemotherapy and Pharmacology (3)
  4. Cancer Research (3)
  5. Cancer (2)
  6. JAMA - Journal of the American Medical Association (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (30)
  2. American Association for Cancer Research (18)
  3. Springer (4)
  4. American Medical Association (2)
  5. Elsevier Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (69)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
    Journal Article

    Maki, R. G.; D'adamo, D. R.; Keohan, M. L.; Saulle, M.; Schuetze, S. M.; Undevia, S. D.; Livingston, M. B.; Cooney, M. M.; Hensley, M. L.; Mita, M. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of flavopiridol with oxaliplatin and fluorouracil/leucovorin in advanced solid tumors
    Journal Article

    Rathkopf, D.; Dickson, M. A.; Feldman, D. R.; Carvajal, R. D.; Shah, M. A.; Wu, N.; Lefkowitz, R.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • γ-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity
    Journal Article

    Meng, R. D.; Shelton, C. C.; Li, Y. M.; Qin, L. X.; Notterman, D.; Paty, P. B.; Schwartz, G. K.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • A phase II study of flavopiridol (alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer
    Journal Article

    Carvajal, R. D.; Tse, A.; Shah, M. A.; Lefkowitz, R. A.; Gonen, M.; Gilman-Rosen, L.; Kortmansky, J.; Kelsen, D. P.; Schwartz, G. K.; O'Reilly, E. M.
    Pancreatology (2009)

    Fulltext@MSK | Save
  • Use of the Notch signaling pathway to predict disease progression and distant recurrence-free survival in early stage colon cancer
    Meeting Abstract

    Meng, R. D.; Qin, L.; Shelton, C. C.; Gerald, W. L.; Barany, F.; Notterman, D.; Li, Y.; Paty, P. B.; Schwartz, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors
    Journal Article

    Tse, A. N.; Klimstra, D. S.; Gonen, M.; Shah, M.; Sheikh, T.; Sikorski, R.; Carvajal, R.; Mui, J.; Tipian, C.; O'reilly, E.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
    Journal Article

    Ku, G. Y.; Ilson, D. H.; Schwartz, L. H.; Capanu, M.; O'reilly, E.; Shah, M. A.; Kelsen, D. P.; Schwartz, G. K.
    Cancer Chemotherapy and Pharmacology (2008)

    Fulltext@MSK | Save
  • A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma
    Journal Article

    Duffy, A.; Kortmansky, J.; Schwartz, G. K.; Capanu, M.; Puleio, S.; Minsky, B.; Saltz, L.; Kelsen, D. P.; O'Reilly, E. M.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing Rad51 expression in a p53-dependent manner
    Journal Article

    Ambrosini, G.; Seelman, S. L.; Qin, L. X.; Schwartz, G. K.
    Cancer Research (2008)

    Fulltext@MSK | Save